Impairment of methylglyoxal detoxification systems causes mitochondrial dysfunction and schizophrenia-like behavioral deficits
Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Takashi Dan(Tohoku University), Yuki Sugaya(The University of Tokyo), Kazuhiro Suzuki(National Institute of Health Sciences), Mai Asakura(Tokyo Metropolitan Matsuzawa Hospital), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Yuki Ogasawara(Meiji Pharmaceutical University), Geneviève Konopka(University of California, Los Angeles), Stefano Berto(Medical University of South Carolina), Takaki Watanabe(The University of Tokyo), Akane Yoshikawa(Tokyo Metropolitan Matsuzawa Hospital), Masanobu Kano(Keio University), Noriyoshi Usui(Osaka City University), Yasue Horiuchi(National Taiwan University), Toshio Miyata(Waseda University), Shin Koike(Meiji Pharmaceutical University), Masanari Itokawa(Fujita Health University)
Cited by 2
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Protein-bound acrolein: Potential markers for oxidative stress
|Proceedings of the National Academy of Sciences|1998|631
Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications
|Kidney International|1999|516
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide
|Nature Cell Biology|2001|474
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326